Form 4 for ONC BeOne Medicines Ltd.
Accepted 2023-12-04 00:00:00 ET · period of report 2023-11-30 · accession 0001651308-23-000167 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-12-04 | 2023-11-30 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | J - Other | $0.00 | -172.4K | 0 | -100% | $0 |
| 2023-12-04 | 2023-11-30 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | G - Gift | $0.00 | -71.9K | 5.46M | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-11-30 | J | D | 172,372 | $0.00 | 0 | I | — | — | (F3) Shares held by adult child that is no longer living in reporting person's household. |
| 2 | Common | Ordinary Shares | 2023-11-30 | G | D | 71,890 | $0.00 | 5,459,438 | D See Footnote | — | — | (F1) Bona fide gift(s) of shares which are exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5. (F4) These securities were held in a UTMA account for the Reporting Person's child, for which the Reporting Person disclaimed beneficial ownership. |